We have a timeline set for how long it will take. I doubt it's shorter than 12 months. So we didn't expected to come to a decision on any of those.
But this is an area where Canada has suffered because there has not been a healthy generic industry in Canada. So what we did with our data protection policy was to make very significant changes. Before, the branded products could in essence evergreen their data protection period by adding in new data at any time they wanted. We put a stop to that. Under our new act, whenever we need or want information, we can demand it of a registrant. So this old custom of the registrant submitting information without our request for it is of no real purpose or use to us. So we set a fixed period for data protection for the branded products, upon which generics can then enter the market very easily. It adds real predictability to the system, which the generic manufacturers told us was needed.